Following our productive Market Engagement process in April, we received responses from over 30 organisations interested in delivering the PaLaDIn Interactium®. The Interactium will be a secure, accessible, user-friendly and high-quality data collection platform, to accelerate the development of effective treatments and patient care, enhance healthcare decision-making and improve patient outcomes. For more information about our vision for the Interactium®, click here.
Since the Market Engagement process began, we have been working across the consortium to collate our views and to consolidate all needs to produce a fuller picture of the requirements for the Interactium.
We are now pleased to announce the opening of the Invitation to Tender stage and anticipate a high degree of interest from the market to become the development partner to TREAT-NMD and the PaLaDIn project and to build the Interactium®. The bid process will be open for the next 4 weeks with an aim to award a contract in September to build and deliver this innovative data platform from then through to the end of 2027.
For more information about this process, click here.
